Publication | Closed Access

Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: Implication of reconstituted tumor microenvironment and multidrug resistance phenotype

Tumor Growth RetardationTumor BiologyLymphoid NeoplasiaOncogenic AgentMedicineImmunologyTumor ImmunityPathologyT Cell LymphomaImmune Checkpoint InhibitorMultidrug Resistance PhenotypeImmunotherapyOncologyTumor MicroenvironmentCancer Research